F. Saglam Et Al. , "Pioglitazone Reduces Peritoneal Fibrosis via Inhibition of TGF-beta, MMP-2, and MMP-9 in a Model of Encapsulating Peritoneal Sclerosis," RENAL FAILURE , vol.34, no.1, pp.95-102, 2012
Saglam, F. Et Al. 2012. Pioglitazone Reduces Peritoneal Fibrosis via Inhibition of TGF-beta, MMP-2, and MMP-9 in a Model of Encapsulating Peritoneal Sclerosis. RENAL FAILURE , vol.34, no.1 , 95-102.
Saglam, F., ÇAVDAR, Z., SARIOĞLU, S., KOLATAN, H. E., OKTAY, G., YILMAZ, O., ... Camsari, T.(2012). Pioglitazone Reduces Peritoneal Fibrosis via Inhibition of TGF-beta, MMP-2, and MMP-9 in a Model of Encapsulating Peritoneal Sclerosis. RENAL FAILURE , vol.34, no.1, 95-102.
Saglam, Funda Et Al. "Pioglitazone Reduces Peritoneal Fibrosis via Inhibition of TGF-beta, MMP-2, and MMP-9 in a Model of Encapsulating Peritoneal Sclerosis," RENAL FAILURE , vol.34, no.1, 95-102, 2012
Saglam, Funda Et Al. "Pioglitazone Reduces Peritoneal Fibrosis via Inhibition of TGF-beta, MMP-2, and MMP-9 in a Model of Encapsulating Peritoneal Sclerosis." RENAL FAILURE , vol.34, no.1, pp.95-102, 2012
Saglam, F. Et Al. (2012) . "Pioglitazone Reduces Peritoneal Fibrosis via Inhibition of TGF-beta, MMP-2, and MMP-9 in a Model of Encapsulating Peritoneal Sclerosis." RENAL FAILURE , vol.34, no.1, pp.95-102.
@article{article, author={Funda Saglam Et Al. }, title={Pioglitazone Reduces Peritoneal Fibrosis via Inhibition of TGF-beta, MMP-2, and MMP-9 in a Model of Encapsulating Peritoneal Sclerosis}, journal={RENAL FAILURE}, year=2012, pages={95-102} }